Primerica, Inc. Form 8-K Summary
Business Context and Reporting Period
Primerica, Inc. filed this Current Report on Form 8-K on May 4, 2016, to announce its results of operations for the quarter ended March 31, 2016. The filing includes a press release (Exhibit 99.1) and supplemental financial information (Exhibit 99.2) regarding the first quarter of 2016.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that these results have been announced and directs investors to the attached exhibits for detailed figures.
Material Changes and Non-GAAP Measures
The Company reports financial results using both GAAP and specific non-GAAP measures to reflect core ongoing operations. Key non-GAAP adjustments include:
- Adjusted Direct and Ceded Premiums: Net of amounts ceded under coinsurance transactions executed concurrent with the initial public offering.
- Operating Revenues and Income: Exclude the impact of realized investment gains and losses.
- Adjusted Stockholders' Equity: Excludes net unrealized investment gains and losses recorded in accumulated other comprehensive income.
Management utilizes these measures for financial planning and performance evaluation, noting they may differ from similar measures used by other companies.
Guidance, Outlook, and Risks
The filing text does not contain specific forward-looking guidance, management commentary on future outlook, or detailed risk factors beyond the standard disclosure that non-GAAP measures have limitations and should not be considered in isolation. The information provided is "furnished" and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2016 revenue, earnings, and premium figures.
- Examine Exhibit 99.2 for supplemental financial data and reconciliations between GAAP and non-GAAP measures.
- Verify the impact of realized and unrealized investment gains/losses on reported equity and income.
- Confirm the treatment of coinsurance transactions in adjusted premium calculations.